Non-invasive Imaging for In-vivo Quantification of Skin Composition and Structure

Launched by HJN SVERIGE AB/NEKO HEALTH · May 8, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new, non-invasive technology that helps measure the structure and function of skin and blood circulation, particularly in people at risk for conditions like diabetes, heart disease, and skin cancer. The goal is to see how well this technology can assess skin health and detect circulation problems compared to existing methods. Participants will be recruited from primary care settings, and the study aims to include adults aged 65 and older who can provide informed consent and are part of regular healthcare visits.

To participate, individuals should have good understanding and communication skills in Swedish or English and must not have significant cognitive impairments or severe medical conditions that could affect their ability to take part. If you decide to join, you can expect to undergo tests that measure your skin and circulation without any invasive procedures, helping researchers learn more about skin health in people with diabetes and cardiovascular risks.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients part of the regular healthcare patient flow at the investigational sites, or as separately invited to participate in this investigation.
• • Patients with signed informed consent
• Exclusion Criteria:
• • Cognitive impairment
• • Patients unable to understand the oral and written study information in Swedish or English
• • Other severe disorder or terminal disease
• • Patients unable to provide an informed consent
• • Patient´s with damaged, scarred or non-intact skin within the skin area of interest.